What does this research mean for the field?

Serological screening and completion of vaccination schedules are crucial for preventing vaccine-preventable viral hepatitis in people living with HIV/AIDS, particularly among those who are not immune. Novelty: ClaimNovelty.CONFIRMATORY. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

What question did this study set out to answer?

Assess the immunity status of men living with HIV/AIDS regarding viral hepatitis and identify associated factors.

February 26, 2026BMC Infectious Diseases0 citationsOpen Access

Vaccine-preventable viral hepatitis in men living with HIV/AIDS – immunity and associated factors

LGLarissa Gerin APAndrey Oeiras Pedroso MAMarcela Antonini

Key Points

Assess the immunity status of men living with HIV/AIDS regarding viral hepatitis and identify associated factors.
Conducted serological screening for vaccine-preventable viral hepatitis
Evaluated vaccination completion rates among men living with HIV/AIDS
Identified factors influencing immunity to viral hepatitis
Found that many individuals were not immune to viral hepatitis
Highlighted a significant gap in vaccination completion among the population
Emphasized the necessity of routine serological screening for this group.

Abstract

Our findings reinforce the importance of serological screening and ensuring the completion of vaccination schedules in all PLWHA, especially among those who are not immune.

AI에게 질문

Bookmark

View Full Paper